CYTOKINETICS INCORPOR
52.22
27-November-24 16:45:00
15 minutes delayed
Stocks
+0.20
+0.38%
Today's range
51.66 - 52.84
ISIN
N/A
Source
NASDAQ
-
01 Sep 2024 03:51:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Participate in September Investor Conferences
29 Aug 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Reports Second Quarter 2024 Financial Results
08 Aug 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
01 Aug 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Call for Proposals for Corporate Giving Program
30 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Announce Second Quarter Results on August 8, 2024
25 Jul 2024 16:00:00 By Nasdaq GlobeNewswire
-
16 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
03 Jul 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants
17 Jun 2024 07:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Jun 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Participate in June Investor Conferences
29 May 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Closing of Public Offering of Common Stock
28 May 2024 16:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Pricing of Public Offering of Common Stock
22 May 2024 23:30:50 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Proposed Public Offering of Common Stock
22 May 2024 16:02:00 By Nasdaq GlobeNewswire
-
22 May 2024 16:00:00 By Nasdaq GlobeNewswire
-
17 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
15 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
13 May 2024 09:33:00 By Nasdaq GlobeNewswire
-
Cytokinetics Reports First Quarter 2024 Financial Results
08 May 2024 16:00:00 By Nasdaq GlobeNewswire